Contribution: Industrial Research Assistance Program – Contributions to Firms
Solutions de Diagnostic Biomark inc.
$169,550.00
Development of a molecular test for the early detection and screening of lung cancer
FY 2021-22 · 2021-10-04
Summary
Development of a non-invasive, highly sensitive and accurate molecular test for the early detection and screening of lung cancer
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Quebec|Québec, Quebec, Canada
Recipient Type
For-profit organization
Business Number
796635662
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 1 | 2021-10-04 | 2021-22 | $169,550.00 |
| 2 | 2021-10-04 | 2021-22 | $169,550.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 50 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 50 jours.
Agreement End Date
2022-10-31
Agreement Number
980330
Agreement Start Date
2021-10-04
Agreement Title
Development of a molecular test for the early detection and screening of lung cancer
Agreement Title (French)
Mise au point d'un test moléculaire pour la détection précoce et le dépistage du cancer du poumon
Agreement Type
Contribution
Agreement Value
$169,550.00
Amendment Date
2022-07-18
Amendment Number
2
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Development of a non-invasive, highly sensitive and accurate molecular test for the early detection and screening of lung cancer
Description (French)
Mise au point d'un test moléculaire non invasif, très sensible et précis pour la détection précoce et le dépistage du cancer du poumon.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Québec
Federal Riding (French)
Québec
Federal Riding Number
24059
NAICS Code
334512
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
796635662
Recipient City
Quebec|Québec
Recipient Country
CA
Recipient Legal Name
Solutions de Diagnostic Biomark inc.
Recipient Operating Name
Biomark Diagnostic Solutions inc.
Recipient Postal Code
G1P 4P5
Recipient Province or Territory
QC
Recipient Type
F
Reference Number
172-2021-2022-Q3-980330
